Concepedia

68Ga-DOTA-NOC PET/CT Imaging of Neuroendocrine Tumors: Comparison with 111In-DTPA-Octreotide (OctreoScan®)

Yodphat Krausz, Nanette Freedman, Rina Rubinstein, E. Lavie, Marina Orevi, Sagi Tshori, Asher Salmon, Benjamin Gläser, Roland Chisin, Eyal Mishani,

Molecular Imaging and Biology · 2010 · 137 citations · 18 references

DOI

Concepts

References

18

68Ga-DOTA-Tyr3-Octreotide PET in Neuroendocrine Tumors: Comparison with Somatostatin Receptor Scintigraphy and CT

Michael Gabriel, Clemens Decristoforo, Dorota Kendler et al. · Journal of Nuclear Medicine · 2007 · 1K citations · Full text

, , +17

Standardized uptake values of normal tissues at PET with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose: variations with body weight and a method for correction.

Kenneth Zasadny, Richard L. Wahl · Radiology · 1993 · 638 citations

, , +15

Comparison of 68Ga-DOTATOC PET and 111In-DTPAOC (Octreoscan) SPECT in patients with neuroendocrine tumours

Inga Buchmann, Marcus Henze, Swantje Engelbrecht et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2007 · 507 citations

, , +14

Processing of Generator-Produced 68Ga for Medical Application

Konstantin Zhernosekov, D. V. Filosofov, Richard P. Baum et al. · Journal of Nuclear Medicine · 2007 · 504 citations · Full text

, , +15

Are radiogallium-labelled DOTA-conjugated somatostatin analogues superior to those labelled with other radiometals?

Pedro Antunes, Mihaela Ginj, Hanwen Zhang et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2007 · 392 citations · Full text

, , +13